Back to News
Jan 14, 2026 8:20 AM

Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies' Mission to Advance Metabolic Wellness Innovation

LAS VEGAS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- MedWatch Technologies today announced that Stead Impact Ventures has committed to lead its $15M Series A financing, supporting the company's mission to advance metabolic wellness through the development of a non-invasive biosensor for glucose-related insight and an integrated lifestyle coaching platform (currently under development).

MedWatch has achieved key technical milestones in the development of its proprietary biosensing technology and is preparing for the next phase of internal testing and commercialization strategy. The lead investment is intended to support continued platform development, technology evaluation, and operational readiness.

In connection with the financing, ...